Disheartening Misconception Regarding ATP7A Shown
The proportions of patients with high AFP levels among those with the HBsAg levels below 500?IU/ml, from 500 to 1,999?IU/ml, from 2,000 to 6,999?IU/ml, from 7,000 to 24,999?IU/ml, and above 25,000?IU/ml were 12.6% (42 of 333 patients), 26.7% (89 of 333), 22.6% (94 of 416), 10.4% (29 of 278), and 6.4% (16 of 250), respectively (Fig. 2A). The relationship between the HBsAg and the AFP levels at the initial visit suggested the presence of two distinct populations within the study group. Especially, in 1,277 patients with the HBsAg levels above 500?IU/ml, a significantly smaller proportion of patients with high AFP levels were noted among those with HBsAg of more than 7,000?IU/ml (8.5%) than those with the HBsAg levels less than 7,000?IU/ml (24.4%) (P?ATP7A to determine Anti-infection Compound Library solubility dmso the relationship between the HBsAg levels and the platelet count at the initial visit. The median platelet counts among patients with the HBsAg levels below 500?IU/ml, from 500 to 1,999?IU/ml, from 2,000 to 6,999?IU/ml, from 7,000 to 24,999?IU/ml, and above 25,000?IU/ml were 19.1?��?104/mm3, 17.2?��?104/mm3, 18.0?��?104/mm3, 20.9?��?104/mm3, and 21.2?��?104/mm3, respectively (Fig. 3A). The relationship between the HBsAg levels and the platelet count at the initial visit also suggested the presence of two distinct populations within the study group. Especially, in 1,277 patients with the HBsAg levels of more than 500?IU/ml, significantly higher platelet counts were noted among those with the HBsAg levels of more than 7,000?IU/ml (the median platelet count; 21.0?��?104/mm3) than those with the HBsAg levels less than 7,000?IU/ml (the median platelet count; 17.6?��?104/mm3) (P?NU7441 concentration Table II summarizes the clinical profiles and laboratory data according to the HBsAg level at the initial visit of 1,610 patients infected with HBV. Patients with the HBsAg levels below 500?IU/ml were significantly older and exhibited lower inflammatory activity (lower levels of AST and ALT), and had lower viral levels (they were HBeAg negative and had lower levels of HBcrAg/HBV DNA), compared to those with the HBsAg levels above 500?IU/ml (P?
